AzTrials
AzTrials

Inguinal HerniaNCT01678638

Timing of Inguinal Hernia Repair in Premature Infants

A study testing IH repair before NICU discharge and IH repair at 55-60 weeks post-menstrual age in people with Inguinal Hernia and Premature Birth of Newborn, run by Vanderbilt University Medical Center at 40 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether early (before NICU discharge) or late (55-60 weeks post-menstrual age) inguinal hernia repair is safer for premature infants who have an inguinal hernia. Read more about this study

Who is it for?
Ages Up to 37 weeks
Conditions the study is for
Inguinal Hernia, Premature Birth of Newborn
What is being tested?
IH repair before NICU discharge and IH repair at 55-60 weeks post-menstrual age
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
338 participants
Where
40 sitesUnited States
Study dates
Jun 2013to Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 37 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infant with estimated gestational age at birth of < 37 weeks, 0 days
  • In a NICU at participating site
  • Diagnosed with an IH per the pediatric surgery team
  • Parents and providers willing to randomize the infant

Who cannot join

  • Infant is undergoing another operative procedure and IH repair is planned as a secondary procedure (e.g. fundoplication or G tube is planned, and IH repair is considered a secondary procedure)
  • Known major congenital anomaly that impacts neurodevelopmental outcome or chromosomal abnormality
  • Family unable to return for follow up and later IH repair; or likely unable to monitor IH as outpatient

Trial locations and contacts

40 sites in 1 country.

40 sites in 1 country

United States40 sites
  • Akron Children's Hospital

    Akron, Ohio, 44308

  • Albany Medical Center

    Albany, New York, 12208

  • University of Alabama at Birmingham School of Medicine; Children's Hospital of Alabama

    Birmingham, Alabama, 35233

  • Tufts Medical Center

    Boston, Massachusetts, 02111

  • Oishei Children's Hospital of Buffalo

    Buffalo, New York, 14203

  • Medical University of South Carolina

    Charleston, South Carolina, 29425

  • UVA Children's Hospital

    Charlottesville, Virginia, 22903

  • Children's Hospital at Erlanger UT Chattanooga

    Chattanooga, Tennessee, 37403

  • Cincinnati Children's Hospital

    Cincinnati, Ohio, 45229

  • Ohio State University College of Medicine; Nationwide Children's Hospital

    Columbus, Ohio, 43205

  • University of Texas, Southwestern Medical Center; Children's Medical Center

    Dallas, Texas, 75235

  • Dayton Children's Hospital

    Dayton, Ohio, 45404

  • Duke University Medical Center; Duke Children's Hospital and Health Center

    Durham, North Carolina, 27710

  • UF Health Shands Children's Hospital

    Gainesville, Florida, 32608

  • Connecticut Children's Medical Center

    Hartford, Connecticut, 06106

  • Baylor College of Medicine; Texas Children's Hospital

    Houston, Texas, 77030

  • University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital

    Houston, Texas, 77030

  • University of Iowa

    Iowa City, Iowa, 52242

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, 03756

  • University of Arkansas for Medical Sciences; Arkansas Children's Hospital

    Little Rock, Arkansas, 72202

  • Southern California Permanente Group

    Los Angeles, California, 90027

  • University of California, Los Angeles David Geffen School of Medicine; Mattel Children's & LA Biomed

    Los Angeles, California, 90095

  • Valley Children's Hospital

    Madera, California, 93636

  • University of Tennessee Health Science Center; Le Bonheur Children's Hospital

    Memphis, Tennessee, 38103

  • Medical College of Wisconsin; Children's Hospital of Wisconsin

    Milwaukee, Wisconsin, 53226

  • University of Minnesota Medical School; Amplatz Children's Hospital

    Minneapolis, Minnesota, 55455

  • Monroe Carell Jr. Children's Hospital at Vanderbilt

    Nashville, Tennessee, 37232

  • Columbia University Irving Medical Center

    New York, New York, 10032

  • Children's Hospital & Medical Center of Omaha

    Omaha, Nebraska, 68114

  • OHSU Doernbecher Children's Hospital

    Portland, Oregon, 97239

  • Women & Infants Hospital of Rhode Island

    Providence, Rhode Island, 02905

  • Cohen Children's Medical Center

    Queens, New York, 11040

  • Virginia Commonwealth University Medical Center; Children's Hospital of Richmond

    Richmond, Virginia, 23284

  • Primary Children's Hospital University of Utah

    Salt Lake City, Utah, 84113

  • Naval Medical Center San Diego

    San Diego, California, 92103

  • UCSD Rady Children's Hospital

    San Diego, California, 92123

  • University of Washington School of Medicine; Seattle Children's Hospital

    Seattle, Washington, 98105

  • SSM Health Cardinal Glennon Children's Hospital

    St Louis, Missouri, 63104

  • Washington University School of Medicine in St. Louis; St. Louis Children's Hospital

    St Louis, Missouri, 63110

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida, 33701

Other trials in United States

About this study

Official title: Timing of Inguinal Hernia Repair in Premature Infants: A Randomized Trial

The purpose of this study is to determine whether early (before NICU discharge) or late (55-60 weeks post-menstrual age) inguinal hernia repair is safer for premature infants who have an inguinal hernia.

Read the detailed description

This is a randomized clinical trial comparing early versus late repair in premature infants with an inguinal hernia (IH) to determine which approach may be safer. Safety in this trial is defined as the freedom from significant adverse events, a reduction in hospital days during the study period, and normal neurodevelopmental testing at 2 years. Costs of each treatment strategy are also important and are being evaluated.

Being tested
IH repair before NICU discharge, IH repair at 55-60 weeks post-menstrual age
Keywords
inguinal hernia, premature infants, anesthesia safety, neurodevelopmental outcome, preterm infants, neonatal prematurity
Medical subject headings
Hernia, Inguinal, Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IH repair before NICU dischargeProcedure or surgery

    The IH repair is performed prior to NICU discharge (within 1-2 weeks of enrollment and randomization)

  • IH repair at 55-60 weeks post-menstrual ageProcedure or surgery

    The IH repair will be performed as an outpatient between approximately 55-60 weeks post-menstrual age.

Study groups in NCT01678638
Study groupRoleWhat they receive
Early inguinal hernia (IH) repairActive comparatorIH repair before NICU discharge
Receives: Procedure: IH repair before NICU discharge
Late inguinal hernia (IH) repairActive comparatorIH repair as outpatient at approximately 55-60 weeks post-menstrual age
Receives: Procedure: IH repair at 55-60 weeks post-menstrual age

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Significant adverse event (SAE) rate

    Specific significant adverse events that are either treatment related or hernia related have been defined a priori and will be assessed in both groups from randomization until 9 months after NICU discharge.

    Measured: 9 months beyond NICU discharge

  2. Number of hospital days

    Total number of hospital days

    Measured: From randomization until 9 months post NICU discharge

Secondary outcomes (2)
  1. Hospital costs

    Departmental level costs at each participating institution will be determined for care that occurs from randomization until 9 months post NICU discharge.

    Measured: Enrollment through 9 months after NICU discharge

  2. Bayley Scales of Infant Development, 3rd Edition

    Mean BSID scores; primarily cognitive domain

    Measured: 22-26 months corrected age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2012 (estimated)
  2. Study startJun 2013
  3. Primary completionApr 2023
  4. Study completionSep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
338 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01678638
Sponsor's protocol ID
11-225-01
Status last verified
Oct 2023
First submitted
30 Aug 2012
Last updated
4 Oct 2023
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • HIP Trial Investigators; Blakely ML, Krzyzaniak A, Dassinger MS, Pedroza C, Weitkamp JH, Gosain A, Cotten M, Hintz SR, Rice H, Courtney SE, Lally KP, Ambalavanan N, Bendel CM, Bui KCT, Calkins C, Chandler NM, Dasgupta R, Davis JM, Deans K, DeUgarte DA, Gander J, Jackson CA, Keszler M, Kling K, Fenton SJ, Fisher KA, Hartman T, Huang EY, Islam S, Koch F, Lainwala S, Lesher A, Lopez M, Misra M, Overbey J, Poindexter B, Russell R, Stylianos S, Tamura DY, Yoder BA, Lucas D, Shaul D, Ham PB 3rd, Fitzpatrick C, Calkins K, Garrison A, de la Cruz D, Abdessalam S, Kvasnovsky C, Segura BJ, Shilyansky J, Smith LM, Tyson JE. Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants: A Randomized Clinical Trial. JAMA. 2024 Mar 26;331(12):1035-1044. doi: 10.1001/jama.2024.2302.

    PubMed 38530261

Questions about this trial

What is this clinical trial studying?

A study testing IH repair before NICU discharge and IH repair at 55-60 weeks post-menstrual age in people with Inguinal Hernia and Premature Birth of Newborn, run by Vanderbilt University Medical Center at 40 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 40 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Significant adverse event (SAE) rate (time frame: 9 months beyond NICU discharge). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01678638, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in